Heart Valve Replacement Market

Global Heart Valve Replacement Market By Material (Mechanical Valve, Biological Valve {Bovine, Porcine}), By Position (Mitral Valve, Tricuspid Valve, Pulmonary Valve, And Aortic Valve), By End User (Hospitals, Ambulatory Surgery Center, and Others), By Approaches (Surgical, Transcatheter {Transfemoral, Transapical, Others}) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)

  • Report ID: HC-67
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 48
  • No. Of Pages: 195
  • Format:
  • Pub. Date: 2020-02-10
  • Share:

Market Outlook:

The global Heart Valve Replacement Market was valued at USD 4,372.3 Million in 2019 and is projected to reach USD 15,139.2 Million by 2027, expanding at a CAGR of 17.5% during the forecast period. Cardiovascular conditions are deteriorating day by day due to rapid changes in the lifestyle such as food consumption habits, lack of exercise and stressful work environment and work-life balance pressure which causes diseases such as aortic stenosis, regurgitation, atresia, prolapse, and valvular stenosis, which, in turn, is responsible for the death of more people than cancer and road accidents put together. Atresia, regurgitation or valvular inadequacy, prolapse and valvular stenosis are some major diseases associated with the heart valve. These diseases can be treated with the help of the replacement or repair of the heart valve.

Global Heart Valve Replacement Market Key Takeaways

Market Dynamics
Major factors driving the market are rising healthcare infrastructure, technology innovation, growing per capita disposable income, adoption of non-invasive technology, awareness regarding the significance of transcatheter devices. Additionally, the less mortality rate over conventional surgical methods, easier to use the device and increasing the success rate of replacing the mitral and aortic heart valve by using transcatheter method is rather better over traditional methods. Increasing prevalence of heart valve disease in Elderly Population and the growing prevalence of severe aortic stenosis disorder and mitral regurgitation. To solve problems about the fluid dynamics associated with the valve designs, various numerical methods have been introduced, which is expected to boost the heart valve replacement market. There are some factor which shows negative impact on the market such as the prohibitive cost of the transcatheter heart valves may interfere with the accessibility of the product in the developing countries of the world. Factors responsible for restraining the growth of the heart replacement market such as the risks and complications associated with heart valve surgeries, such as breathing problems and embolism, and inadequacy of primary healthcare infrastructure in developing countries.
 

Segmental Outlook

On the basis of Material type, the global Heart Valve Replacement Market is divided as biological and mechanical. The mechanical valve segment is anticipated to expand at a CAGR of around 16% during the forecast period as majorly used to make mechanical heart valves are made from titanium and carbon. In biological segment, Bovine segment anticipated to expand at a CAGR approximately 15.7% during forecast period.

Global Heart Valve Replacement Market By Material

Based on position, the market is segmented into mitral valve, tricuspid valve, pulmonary valve, and aortic valve. The mitral valve segment is projected to hold a major share of the market during the forecast period as cases related to mitral valve increases.

Based on end-users, the market is segmented into hospitals, ambulatory surgery center, and others. Hospitals account for the major share as majority of the people received treatment for the heart valve from the hospitals, including the ambulatory surgery centers.

Based on approaches, the market is divided into surgical, transcatheter. Transcatheter account for the major share as majority of the people inclined towards transcatheter approach. In transcatheter segment, transfemoral accounts for major share as it is entering through the femoral artery (large artery in the groin), which does not require a surgical incision in the chest.
 

Definitions

By Position

Aortic Valve: The aortic valve is a valve in the human heart between the left ventricle and the aorta. It is one of the two semilunar valves of the heart, the former being the pulmonary valve. The heart has four valves; the other two are the mitral and the tricuspid valves. Aortic valve is located between the left ventricle and the aorta (the large blood vessel that carries blood to the rest of the body). When your ventricle contracts, blood is forced through the aortic valve, into the aorta, and out to the rest of your body.

Mitral Valve: Mitral valve is a valve with two flaps in the heart, present between the left ventricle and left atrium, and it is also known as bicuspid valve or left atrioventricular valve. The tricuspid valve and mitral valve are known as the atrioventricular valves because they are present between the ventricles and the atria of the heart.

Pulmonary Valve: The pulmonic valve, also known as a pulmonary valve, is the semilunar valve of the heart which lies between the pulmonary artery, right ventricle and has three cusps. The pulmonary artery opens in ventricular systole whenever the pressure in the right ventricle rises above the pressure in the pulmonary artery, similar to the aortic valve. When the pressure in the right ventricle falls rapidly at the end of the ventricular systole, the pulmonary valve will be closed by the pressure of the pulmonary artery.

Tricuspid Valve: The tricuspid valve also known as a right atrioventricular valve, is present at the superior portion of the right ventricle, on the dorsal side of the mammalian heart. The main function of this valve is to prevent the backflow of blood from the right ventricle to the right atrium during right ventricular contraction called systole.

Global Heart Valve Replacement Market By Position

Regional Outlook

In terms of regions, the market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a promising region for the market. The region constituted around 35.5% share of the market in 2020. The market in the region is projected to expand at a CAGR of around 15.8% during the forecast period as there is increase in heart related diseases in North America, increasing focus of players in drug development and heart valve replacement therapy development, rise in government initiatives are some of the factors expected to boost the market growth on the region.
 

Competitive Landscape

  • Key players in the market include VENUS MEDTECH, Abbott, Boston Scientific Corporation, Colibri Heart Valve, CryoLife, Inc., Edwards Lifesciences Corporation, HLT, Inc., JenaValve Technology, Inc. LifeNet Health., Medtronic, Meril Life Sciences Pvt. Ltd. These companies are considered manufacturers of heart valve replacement based on their regional presence, revenue, supply chain management system, and research development (R&D) activities.
  • The players are adopting key strategies such as acquisition, and geographical expansion where potential opportunity for the heart valve replacement is added in the company’s capacity.
  • For instance, in 2015, Edwards Lifesciences Corporation announced the acquisition of CardiAQ. CardiAQ Valve Technologies, Inc., a privately held company and developer of a transcatheter mitral valve replacement system. This action of the company helps them to increase product portfolio.
  •  In 2017, Medtronic Expanded Heart Valve Portfolio with FDA Approval and CE Mark of the Avalus (TM) Surgical Aortic Valve.

Global Heart Valve Replacement Market By Manufacturer

Key Benefits for Industry Participants & Stakeholders

  • In-depth Analysis of the Global Heart Valve Replacement Market
  • Historical, Current and Projected Market Size in terms of Value
  • Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
  • Industry Drivers, Restraints and Opportunities Covered in the Study
  • Recent Industry Trends and Developments
  • Competitive Landscape & Strategies of Key Players
  • Neutral Perspective on Global Heart Valve Replacement Market Performance
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Heart Valve Replacement Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Heart Valve Replacement Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Heart Valve Replacement Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Heart Valve Replacement Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Heart Valve Replacement Market Size & Forecast, 2017-2027
      4.5.1 Heart Valve Replacement Market Size and Y-o-Y Growth
      4.5.2 Heart Valve Replacement Market Absolute $ Opportunity
   4.6 Patient Incidence Data
Chapter 5 Global Heart Valve Replacement Market Analysis and Forecast By Material
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Material
      5.1.2 Basis Point Share (BPS) Analysis By Material
      5.1.3 Absolute $ Opportunity Assessment By Material
   5.2 Heart Valve Replacement Market Size Forecast By Material
      5.2.1 Mechanical Valve
      5.2.2  Biological Valve
         5.2.2.1 Porcine
         5.2.2.2 Bovine
   5.3 Market Attractiveness Analysis By Material
Chapter 6 Global Heart Valve Replacement Market Analysis and Forecast By Position
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Position
      6.1.2 Basis Point Share (BPS) Analysis By Position
      6.1.3 Absolute $ Opportunity Assessment By Position
   6.2 Heart Valve Replacement Market Size Forecast By Position
      6.2.1 Mitral Valve
      6.2.2 Tricuspid Valve
      6.2.3 Pulmonary Valve
      6.2.4 Aortic Valve
   6.3 Market Attractiveness Analysis By Position
Chapter 7 Global Heart Valve Replacement Market Analysis and Forecast By End User
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By End User
      7.1.2 Basis Point Share (BPS) Analysis By End User
      7.1.3 Absolute $ Opportunity Assessment By End User
   7.2 Heart Valve Replacement Market Size Forecast By End User
      7.2.1 Hospitals
      7.2.2 Ambulatory Surgery Center
      7.2.3 Others
   7.3 Market Attractiveness Analysis By End User
Chapter 8 Global Heart Valve Replacement Market Analysis and Forecast By Approaches
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities By Approaches
      8.1.2 Basis Point Share (BPS) Analysis By Approaches
      8.1.3 Absolute $ Opportunity Assessment By Approaches
   8.2 Heart Valve Replacement Market Size Forecast By Approaches
      8.2.1 Surgical
      8.2.2 Transcatheter
         8.2.2.1 Transfemoral
         8.2.2.2 Transapical
         8.2.2.3 Others
   8.3 Market Attractiveness Analysis By Approaches
Chapter 9 Global Heart Valve Replacement Market Analysis and Forecast by Region
   9.1 Introduction
      9.1.1 Key Market Trends & Growth Opportunities by Region
      9.1.2 Basis Point Share (BPS) Analysis by Region
      9.1.3 Absolute $ Opportunity Assessment by Region
   9.2 Heart Valve Replacement Market Size Forecast by Region
      9.2.1 North America
      9.2.2 Europe
      9.2.3 Asia Pacific
      9.2.4 Latin America
      9.2.5 Middle East & Africa (MEA)
   9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
   10.1 Introduction
   10.2 Current & Future Impact Analysis
   10.3 Economic Impact Analysis
   10.4 Government Policies
   10.5 Investment Scenario
Chapter 11 North America Heart Valve Replacement Analysis and Forecast
   11.1 Introduction
   11.2 North America Heart Valve Replacement Market Size Forecast by Country
      11.2.1 U.S.
      11.2.2 Canada
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 North America Heart Valve Replacement Market Size Forecast By Material
      11.6.1 Mechanical Valve
      11.6.2  Biological Valve
         11.6.2.1 Porcine
         11.6.2.2 Bovine
   11.7 Basis Point Share (BPS) Analysis By Material
   11.8 Absolute $ Opportunity Assessment By Material
   11.9 Market Attractiveness Analysis By Material
   11.10 North America Heart Valve Replacement Market Size Forecast By Position
      11.10.1 Mitral Valve
      11.10.2 Tricuspid Valve
      11.10.3 Pulmonary Valve
      11.10.4 Aortic Valve
   11.11 Basis Point Share (BPS) Analysis By Position
   11.12 Absolute $ Opportunity Assessment By Position
   11.13 Market Attractiveness Analysis By Position
   11.14 North America Heart Valve Replacement Market Size Forecast By End User
      11.14.1 Hospitals
      11.14.2 Ambulatory Surgery Center
      11.14.3 Others
   11.15 Basis Point Share (BPS) Analysis By End User
   11.16 Absolute $ Opportunity Assessment By End User
   11.17 Market Attractiveness Analysis By End User
   11.18 North America Heart Valve Replacement Market Size Forecast By Approaches
      11.18.1 Surgical
      11.18.2 Transcatheter
         11.18.2.1 Transfemoral
         11.18.2.2 Transapical
         11.18.2.3 Others
   11.19 Basis Point Share (BPS) Analysis By Approaches
   11.20 Absolute $ Opportunity Assessment By Approaches
   11.21 Market Attractiveness Analysis By Approaches
Chapter 12 Europe Heart Valve Replacement Analysis and Forecast
   12.1 Introduction
   12.2 Europe Heart Valve Replacement Market Size Forecast by Country
      12.2.1 Germany
      12.2.2 France
      12.2.3 Italy
      12.2.4 U.K.
      12.2.5 Spain
      12.2.6 Russia
      12.2.7 Rest of Europe
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Europe Heart Valve Replacement Market Size Forecast By Material
      12.6.1 Mechanical Valve
      12.6.2  Biological Valve
         12.6.2.1 Porcine
         12.6.2.2 Bovine
   12.7 Basis Point Share (BPS) Analysis By Material
   12.8 Absolute $ Opportunity Assessment By Material
   12.9 Market Attractiveness Analysis By Material
   12.10 Europe Heart Valve Replacement Market Size Forecast By Position
      12.10.1 Mitral Valve
      12.10.2 Tricuspid Valve
      12.10.3 Pulmonary Valve
      12.10.4 Aortic Valve
   12.11 Basis Point Share (BPS) Analysis By Position
   12.12 Absolute $ Opportunity Assessment By Position
   12.13 Market Attractiveness Analysis By Position
   12.14 Europe Heart Valve Replacement Market Size Forecast By End User
      12.14.1 Hospitals
      12.14.2 Ambulatory Surgery Center
      12.14.3 Others
   12.15 Basis Point Share (BPS) Analysis By End User
   12.16 Absolute $ Opportunity Assessment By End User
   12.17 Market Attractiveness Analysis By End User
   12.18 Europe Heart Valve Replacement Market Size Forecast By Approaches
      12.18.1 Surgical
      12.18.2 Transcatheter
         12.18.2.1 Transfemoral
         12.18.2.2 Transapical
         12.18.2.3 Others
   12.19 Basis Point Share (BPS) Analysis By Approaches
   12.20 Absolute $ Opportunity Assessment By Approaches
   12.21 Market Attractiveness Analysis By Approaches
Chapter 13 Asia Pacific Heart Valve Replacement Analysis and Forecast
   13.1 Introduction
   13.2 Asia Pacific Heart Valve Replacement Market Size Forecast by Country
      13.2.1 China
      13.2.2 Japan
      13.2.3 South Korea
      13.2.4 India
      13.2.5 Australia
      13.2.6 South East Asia (SEA)
      13.2.7 Rest of Asia Pacific (APAC)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Asia Pacific Heart Valve Replacement Market Size Forecast By Material
      13.6.1 Mechanical Valve
      13.6.2  Biological Valve
         13.6.2.1 Porcine
         13.6.2.2 Bovine
   13.7 Basis Point Share (BPS) Analysis By Material
   13.8 Absolute $ Opportunity Assessment By Material
   13.9 Market Attractiveness Analysis By Material
   13.10 Asia Pacific Heart Valve Replacement Market Size Forecast By Position
      13.10.1 Mitral Valve
      13.10.2 Tricuspid Valve
      13.10.3 Pulmonary Valve
      13.10.4 Aortic Valve
   13.11 Basis Point Share (BPS) Analysis By Position
   13.12 Absolute $ Opportunity Assessment By Position
   13.13 Market Attractiveness Analysis By Position
   13.14 Asia Pacific Heart Valve Replacement Market Size Forecast By End User
      13.14.1 Hospitals
      13.14.2 Ambulatory Surgery Center
      13.14.3 Others
   13.15 Basis Point Share (BPS) Analysis By End User
   13.16 Absolute $ Opportunity Assessment By End User
   13.17 Market Attractiveness Analysis By End User
   13.18 Asia Pacific Heart Valve Replacement Market Size Forecast By Approaches
      13.18.1 Surgical
      13.18.2 Transcatheter
         13.18.2.1 Transfemoral
         13.18.2.2 Transapical
         13.18.2.3 Others
   13.19 Basis Point Share (BPS) Analysis By Approaches
   13.20 Absolute $ Opportunity Assessment By Approaches
   13.21 Market Attractiveness Analysis By Approaches
Chapter 14 Latin America Heart Valve Replacement Analysis and Forecast
   14.1 Introduction
   14.2 Latin America Heart Valve Replacement Market Size Forecast by Country
      14.2.1 Brazil
      14.2.2 Mexico
      14.2.3 Rest of Latin America (LATAM)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Latin America Heart Valve Replacement Market Size Forecast By Material
      14.6.1 Mechanical Valve
      14.6.2  Biological Valve
         14.6.2.1 Porcine
         14.6.2.2 Bovine
   14.7 Basis Point Share (BPS) Analysis By Material
   14.8 Absolute $ Opportunity Assessment By Material
   14.9 Market Attractiveness Analysis By Material
   14.10 Latin America Heart Valve Replacement Market Size Forecast By Position
      14.10.1 Mitral Valve
      14.10.2 Tricuspid Valve
      14.10.3 Pulmonary Valve
      14.10.4 Aortic Valve
   14.11 Basis Point Share (BPS) Analysis By Position
   14.12 Absolute $ Opportunity Assessment By Position
   14.13 Market Attractiveness Analysis By Position
   14.14 Latin America Heart Valve Replacement Market Size Forecast By End User
      14.14.1 Hospitals
      14.14.2 Ambulatory Surgery Center
      14.14.3 Others
   14.15 Basis Point Share (BPS) Analysis By End User
   14.16 Absolute $ Opportunity Assessment By End User
   14.17 Market Attractiveness Analysis By End User
   14.18 Latin America Heart Valve Replacement Market Size Forecast By Approaches
      14.18.1 Surgical
      14.18.2 Transcatheter
         14.18.2.1 Transfemoral
         14.18.2.2 Transapical
         14.18.2.3 Others
   14.19 Basis Point Share (BPS) Analysis By Approaches
   14.20 Absolute $ Opportunity Assessment By Approaches
   14.21 Market Attractiveness Analysis By Approaches
Chapter 15 Middle East & Africa (MEA) Heart Valve Replacement Analysis and Forecast
   15.1 Introduction
   15.2 Middle East & Africa (MEA) Heart Valve Replacement Market Size Forecast by Country
      15.2.1 Saudi Arabia
      15.2.2 South Africa
      15.2.3 UAE
      15.2.4 Rest of Middle East & Africa (MEA)
   15.3 Basis Point Share (BPS) Analysis by Country
   15.4 Absolute $ Opportunity Assessment by Country
   15.5 Market Attractiveness Analysis by Country
   15.6 Middle East & Africa (MEA) Heart Valve Replacement Market Size Forecast By Material
      15.6.1 Mechanical Valve
      15.6.2  Biological Valve
         15.6.2.1 Porcine
         15.6.2.2 Bovine
   15.7 Basis Point Share (BPS) Analysis By Material
   15.8 Absolute $ Opportunity Assessment By Material
   15.9 Market Attractiveness Analysis By Material
   15.10 Middle East & Africa (MEA) Heart Valve Replacement Market Size Forecast By Position
      15.10.1 Mitral Valve
      15.10.2 Tricuspid Valve
      15.10.3 Pulmonary Valve
      15.10.4 Aortic Valve
   15.11 Basis Point Share (BPS) Analysis By Position
   15.12 Absolute $ Opportunity Assessment By Position
   15.13 Market Attractiveness Analysis By Position
   15.14 Middle East & Africa (MEA) Heart Valve Replacement Market Size Forecast By End User
      15.14.1 Hospitals
      15.14.2 Ambulatory Surgery Center
      15.14.3 Others
   15.15 Basis Point Share (BPS) Analysis By End User
   15.16 Absolute $ Opportunity Assessment By End User
   15.17 Market Attractiveness Analysis By End User
   15.18 Middle East & Africa (MEA) Heart Valve Replacement Market Size Forecast By Approaches
      15.18.1 Surgical
      15.18.2 Transcatheter
         15.18.2.1 Transfemoral
         15.18.2.2 Transapical
         15.18.2.3 Others
   15.19 Basis Point Share (BPS) Analysis By Approaches
   15.20 Absolute $ Opportunity Assessment By Approaches
   15.21 Market Attractiveness Analysis By Approaches
Chapter 16 Competition Landscape
   16.1 Heart Valve Replacement Market: Competitive Dashboard
   16.2 Global Heart Valve Replacement Market: Market Share Analysis, 2019
   16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      16.3.1 Abbott.
      16.3.2 Boston Scientific Corporation 
      16.3.3 Colibri Heart Valve
      16.3.4 CryoLife, Inc.
      16.3.5 Edwards Lifesciences Corporation
      16.3.6 HLT, Inc.
      16.3.7 JenaValve Technology, Inc.
      16.3.8 LifeNet Health.
      16.3.9 Medtronic
      16.3.10 Meril Life Sciences Pvt. Ltd.
      16.3.11 VENUS MEDTECH
Key Segments Covered
By Material
  • Mechanical Valve
  • Biological Valve
    • Bovine
    • Porcine
By Position
  • Mitral Valve
  • Tricuspid Valve
  • Pulmonary Valve
  • Aortic Valve
By End User
  • Hospitals
  • Ambulatory Surgery Center
  • Others
By Approches
  • Surgical
  • Transcatheter
  • Transfemoral
  • Transapical
  • Others
By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Spain
    • Poland
    • Rest of the Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of MEA

Key Market Players Profiled in the Report
  • Edwards Lifesciences Corporation
  • Medtronic
  • Abbott.
  • Boston Scientific Corporation
  • Meril Life Sciences Pvt. Ltd.
  • HLT, Inc.
  • JenaValve Technology, Inc.
  • LifeNet Health.
  • CryoLife, Inc.
  • Colibri Heart Valve
  • VENUS MEDTECH

Buy Report

FAQ Section

Some frequently asked quetions about this report!

Additional company profiles can be provided on request.

According to this Growth Market Reports report, the market from heart valve replacement is likely to register a CAGR of around 17.5% during forecast period 2020-2027, with an anticipated valuation of USD 15,139.2 million by the end of the 2027.

In addition to market size (in US$ Million) and Company market share (in % for base year 2019), other data such as patient incidence data, cross-section segment data by segments, cross-section segment data by countries, market size by country along with segment split is provided for heart valve replacement market is available in final report.

Major factors driving the market are rising healthcare infrastructure, technology innovation, growing per capita disposable income, adoption of non-invasive technology, awareness regarding the significance of transcatheter devices.

GDP, disposable income, healthcare factors, urbanization, and political factors are included in macro-economic factors.

Hospitals are the key end-user that are driving the heart valve replacement market.

Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.

The market is expected to witness slight stagnancy between 2019 and 2020 owing to the slight impact of COVID-19 pandemic on the heart valve replacement market.

The base year considered for the global heart valve replacement market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years and the forecast is provided from 2020 to 2027.

Major Manufactures include, VENUS MEDTECH, Abbott, Boston Scientific Corporation, Colibri Heart Valve, CryoLife, Inc., Edwards Lifesciences Corporation, HLT, Inc., JenaValve Technology, Inc. LifeNet Health., Medtronic, Meril Life Sciences Pvt. Ltd.